| Study Name | Indication | Description | Location | Stipend | Apply |
|---|---|---|---|---|---|
| Abbvie M16-852 | Giant Cell Arteritis | A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis | Vandalia, Ohio | $1900 | Apply |
| CA41705 | Lupus Nephritis | A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OBINUTUZUMAB IN PATIENTS WITH ISN/RPS 2003 CLASS III OR IV LUPUS NEPHRITIS | Vandalia, Ohio | $1892 | Apply |
| AFFINITY (PSA2003) | Psoriatic Arthritis | A Phase 2a, Multicenter, Randomized, Double-blind Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis | Vandalia, Ohio | $936 | Apply |
| SOLSTICE (PSA3005) | Psoriatic Arthritis | A Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants with Active Psoriatic Arthritis who had an Inadequate Response and/or Intolerance to One Prior Anti-Tumor Necrosis Factor [alpha] Agent | Vandalia, Ohio | $1300 | Apply |
| STAR (PSA4002) | Psoriatic Arthritis | A Phase 4, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Bio-naive Participants with Active Psoriatic Arthritis Axial Disease | Vandalia, Ohio | $1300 | Apply |
| AS-001 | Ankylosing Spondylitis | Vandalia, Ohio | $235 | Apply | |
| APEX (PSA3004) | Psoriatic Arthritis | A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab in Improving the Signs and Symptoms and Inhibiting Radiographic Progression in Participants with Active Psoriatic Arthritis. | Springboro, Ohio | $0 | Apply |
Enrolling Studies
Below is the list of studies which are currently open for enrollment to those who qualify.
Upcoming Studies
Here is a list of the studies which we are not currently enrolling but expect to begin soon...
We currently do not have an upcoming studies to report.
How long do studies typically remain open for enrollment?
Studies typically have an enrollment period of about 6-months to a year. Of course, some studies enrollment windows are much shorter or longer depending on the enrollment criteria.
How many patients get enrolled on a study?
Most studies we conduct are multi-center studies, meaning there are many sites enrolling the same study across the country or globally. At STAT Research, we typically have enrollment numbers between 1 to 10 per study.
